Fig. 5From: Exploring the underlying mechanisms of fisetin in the treatment of hepatic insulin resistance via network pharmacology and in vitro validationA The compound-targets-disease network. The yellow arrow represented fisetin, the red diamond represented hepatic IR, and blue circle represented the targets. B PI3K/AKT signaling pathway. The red lines show the possible signaling pathways through which fisetin acted on the hepatic IRBack to article page